Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study
about
sameAs
The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situThe diagnosis and management of pre-invasive breast disease: pathological diagnosis--problems with existing classificationsAtypical epithelial hyperplasia of the breast: state of the art.Atypical hyperplasia of the breast--risk assessment and management options.Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study.Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.Clinician's guide to imaging and pathologic findings in benign breast disease.How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?Lobular neoplasia detected in MRI-guided core biopsy carries a high risk for upgrade: a study of 63 cases from four different institutions.Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow-up in a multidisciplinary settingAccuracy of screening mammography in women with a history of lobular carcinoma in situ or atypical hyperplasia of the breast.Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer RiskBreast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program.Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy.Lobular neoplasia: frequency and association with other breast lesions.Breast lesions, pathology and cancer risk.Molecular drivers of lobular carcinoma in situ.Precursors and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma.Early Breast Cancer Precursor Lesions: Lessons Learned from Molecular and Clinical StudiesBreast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer.Non-operative breast pathology: lobular neoplasiaBiologic characteristics of premalignant breast disease.Genomics and premalignant breast lesions: clues to the development and progression of lobular breast cancerThe significance of lobular neoplasia on needle core biopsy of the breastHigh-risk benign breast lesions: current strategies in management.Estrogen plus progestin and risk of benign proliferative breast disease.Benign breast disease, mammographic breast density, and the risk of breast cancer.Serial analysis of gene expression of lobular carcinoma in situ identifies down regulation of claudin 4 and overexpression of matrix metalloproteinase 9.Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women.A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease.Low-fat dietary pattern and risk of benign proliferative breast disease: a randomized, controlled dietary modification trial.Lobular neoplasia: morphology, biological potential and management in core biopsies.The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy.Current management of lesions associated with an increased risk of breast cancer.Breast cancer risk associated with benign breast disease: systematic review and meta-analysis.Amplification of the prolactin receptor gene in mammary lobular neoplasia.E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast.Incidental Findings in Reduction Mammoplasty Specimens in Patients with No Prior History of Breast Cancer. An Analysis of 783 Specimens.
P2860
Q24803386-C17BE651-8E54-49C3-BA5A-2C50E968C697Q24803517-58402B0B-1C4A-4DA6-8E88-7364D5A22AECQ30249199-107339B1-34A1-462B-B39B-8961C438DD9FQ30301033-548BCDA0-3E13-4BF2-8404-CA895DC02F8EQ30408300-7C0BEBD2-FF47-4504-8C7C-4306E7222DD2Q33569159-4CF0E23E-A686-4C44-A1FF-A65107088EC8Q33744173-AB5B4CB9-4340-4456-BCB6-C0A1F6B7FE4EQ33767120-58B3DF5D-B192-49F1-8A79-FD80FAC48F37Q33855742-B6A78D2A-CE02-4472-990C-B847186B6E03Q33913513-B96B95BA-F21E-4289-AE92-C065E9800228Q33952112-19D80E1E-542A-4D2B-B353-6EED16E2FB36Q34038325-8AE41310-980A-4799-B39E-D284C93EA4D9Q34044916-93A4E0EE-1CB2-450E-811B-5B065AED2320Q34983619-F59DB869-2000-407E-86CD-0C38EE0BF6DEQ35193877-617BFC62-E601-494F-8E68-E601C349BB5BQ35207074-59A1776E-B69E-48E2-8709-2A46359234FEQ35675835-FACB8551-91B8-460B-9CBC-8BB421088A98Q35676504-7F1EBAA3-C3A0-4417-AF04-03B90418C032Q35846896-BB0CF954-70DA-48D5-975D-04C2FBD10D4FQ35940073-966160AE-0E64-471C-BF04-EB197730DD93Q36090967-00740BBE-E832-4187-A793-12F033D1A23CQ36172476-31B775A8-0891-471E-AA91-ADCA3B88F793Q36204798-85267372-FFA5-4A4D-B1D9-9514078C9DCEQ36465250-A4005443-D707-4598-A867-6C11B00E64E2Q36579505-D3C5B61D-4DE5-47BD-A918-BDE4A1FB2797Q36959818-690D3116-000A-4CC2-B9A1-F1E6D6401502Q36976159-50F9B5DB-9FF9-4DC6-914F-B4B7CE176865Q37021220-BCBF0FFC-AB29-4DFD-9BA5-7BA5F979C50FQ37038590-DEB00B13-1E04-482E-ABF0-7DF81DB8C45BQ37270445-6015457D-7F88-4F2D-A715-82E95C8C340DQ37293304-F714F9E2-DDE2-413E-ADAB-5EEF1C8C7DA3Q37367067-619C6C8D-FD45-4CCC-A97F-7429A69A1CA3Q37740943-05767A18-0014-4A8D-9C48-4742D59699FBQ37834472-01545D33-649D-4285-B8AC-CD95FCC3C8D9Q37921206-FF8A91BE-384F-45D0-9335-F89C8BB1E92CQ38333149-8FA8D628-6A2D-4A31-BE3F-EC756F4EEFC8Q38338001-405C45FD-F306-4C03-9126-10F851EC492FQ38415541-A891C3CF-DD54-48DE-B8D2-00E35F737E9FQ38444030-E58721D5-0325-441A-BCC2-514F643AA211Q38845987-B2E77CE7-016B-4907-A491-2B205B579048
P2860
Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Atypical lobular hyperplasia a ...... : a retrospective cohort study
@ast
Atypical lobular hyperplasia a ...... : a retrospective cohort study
@en
Atypical lobular hyperplasia a ...... : a retrospective cohort study
@nl
type
label
Atypical lobular hyperplasia a ...... : a retrospective cohort study
@ast
Atypical lobular hyperplasia a ...... : a retrospective cohort study
@en
Atypical lobular hyperplasia a ...... : a retrospective cohort study
@nl
prefLabel
Atypical lobular hyperplasia a ...... : a retrospective cohort study
@ast
Atypical lobular hyperplasia a ...... : a retrospective cohort study
@en
Atypical lobular hyperplasia a ...... : a retrospective cohort study
@nl
P2093
P1433
P1476
Atypical lobular hyperplasia a ...... : a retrospective cohort study
@en
P2093
David L Page
Jean F Simpson
Peggy A Schuyler
Roy A Jensen
W Dale Plummer
P356
10.1016/S0140-6736(03)12230-1
P407
P577
2003-01-11T00:00:00Z